Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
17.48
USD
|
+0.63%
|
|
+7.97%
|
+23.45%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,620
|
2,099
|
3,697
|
2,118
|
2,220
|
2,759
|
-
|
-
|
Enterprise Value (EV)
1 |
4,344
|
4,801
|
6,045
|
4,492
|
4,771
|
5,235
|
5,146
|
5,034
|
P/E ratio
|
-14.6
x
|
-
|
13.3
x
|
4.34
x
|
-
|
49.9
x
|
16.6
x
|
12.9
x
|
Yield
|
1.58%
|
1.92%
|
1.5%
|
3.65%
|
-
|
3.21%
|
3.2%
|
3.37%
|
Capitalization / Revenue
|
0.61
x
|
0.76
x
|
1.04
x
|
0.61
x
|
0.78
x
|
0.9
x
|
0.83
x
|
0.8
x
|
EV / Revenue
|
1.64
x
|
1.74
x
|
1.69
x
|
1.3
x
|
1.67
x
|
1.7
x
|
1.55
x
|
1.45
x
|
EV / EBITDA
|
7.06
x
|
7.19
x
|
6.38
x
|
5.13
x
|
9.11
x
|
8.8
x
|
6.86
x
|
6.24
x
|
EV / FCF
|
20.3
x
|
30
x
|
12.9
x
|
26.4
x
|
-62
x
|
29.6
x
|
15.6
x
|
12.4
x
|
FCF Yield
|
4.93%
|
3.33%
|
7.74%
|
3.78%
|
-1.61%
|
3.38%
|
6.41%
|
8.08%
|
Price to Book
|
2.17
x
|
1.24
x
|
1.86
x
|
0.9
x
|
1.15
x
|
1.39
x
|
1.31
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
141,889
|
143,557
|
153,867
|
154,465
|
156,794
|
157,838
|
-
|
-
|
Reference price
2 |
11.42
|
14.62
|
24.03
|
13.71
|
14.16
|
17.48
|
17.48
|
17.48
|
Announcement Date
|
2/25/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,642
|
2,758
|
3,572
|
3,454
|
2,850
|
3,075
|
3,324
|
3,467
|
EBITDA
1 |
615
|
668
|
947
|
875
|
524
|
594.9
|
750.4
|
807
|
EBIT
1 |
303
|
334
|
619
|
580
|
249
|
302.2
|
445.8
|
497.5
|
Operating Margin
|
11.47%
|
12.11%
|
17.33%
|
16.79%
|
8.74%
|
9.83%
|
13.41%
|
14.35%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
308
|
49
|
104.4
|
287.6
|
340.9
|
Net income
1 |
-109
|
969
|
286
|
497
|
-316
|
85.81
|
219.7
|
260.2
|
Net margin
|
-4.13%
|
35.13%
|
8.01%
|
14.39%
|
-11.09%
|
2.79%
|
6.61%
|
7.51%
|
EPS
2 |
-0.7800
|
-
|
1.810
|
3.160
|
-
|
0.3500
|
1.050
|
1.350
|
Free Cash Flow
1 |
214
|
160
|
468
|
170
|
-77
|
177
|
330
|
407
|
FCF margin
|
8.1%
|
5.8%
|
13.1%
|
4.92%
|
-2.7%
|
5.76%
|
9.93%
|
11.74%
|
FCF Conversion (EBITDA)
|
34.8%
|
23.95%
|
49.42%
|
19.43%
|
-
|
29.76%
|
43.98%
|
50.43%
|
FCF Conversion (Net income)
|
-
|
16.51%
|
163.64%
|
34.21%
|
-
|
206.27%
|
150.17%
|
156.4%
|
Dividend per Share
2 |
0.1800
|
0.2800
|
0.3600
|
0.5000
|
-
|
0.5612
|
0.5586
|
0.5895
|
Announcement Date
|
2/25/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
870
|
884
|
965
|
945
|
895
|
649
|
708
|
794
|
662
|
686
|
750
|
824.7
|
778.7
|
747.6
|
853.3
|
EBITDA
1 |
252
|
233
|
240
|
275
|
247
|
113
|
146
|
168
|
116
|
94
|
118.6
|
147.9
|
172
|
156.6
|
182
|
EBIT
1 |
168
|
155
|
154
|
190
|
163
|
40
|
62
|
84
|
32
|
25
|
46.4
|
75.18
|
96.21
|
91.2
|
118.1
|
Operating Margin
|
19.31%
|
17.53%
|
15.96%
|
20.11%
|
18.21%
|
6.16%
|
8.76%
|
10.58%
|
4.83%
|
3.64%
|
6.19%
|
9.12%
|
12.36%
|
12.2%
|
13.84%
|
Earnings before Tax (EBT)
1 |
141
|
104
|
34
|
152
|
141
|
-19
|
34
|
53
|
-6
|
-32
|
-2
|
11
|
30
|
33
|
-
|
Net income
1 |
111
|
83
|
16
|
375
|
121
|
-15
|
23
|
-269
|
-14
|
-56
|
-3
|
9
|
24
|
26
|
-
|
Net margin
|
12.76%
|
9.39%
|
1.66%
|
39.68%
|
13.52%
|
-2.31%
|
3.25%
|
-33.88%
|
-2.11%
|
-8.16%
|
-0.4%
|
1.09%
|
3.08%
|
3.48%
|
-
|
EPS
2 |
0.7000
|
0.5200
|
0.1000
|
2.370
|
0.7700
|
-0.0900
|
0.1500
|
-1.720
|
-0.0900
|
-0.3600
|
-0.0200
|
0.0500
|
0.1500
|
0.1700
|
-
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
-
|
-
|
0.1403
|
0.1403
|
0.1403
|
0.1403
|
0.1543
|
Announcement Date
|
10/27/21
|
2/16/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/15/23
|
4/26/23
|
7/26/23
|
10/25/23
|
2/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,724
|
2,702
|
2,348
|
2,374
|
2,551
|
2,476
|
2,387
|
2,275
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.429
x
|
4.045
x
|
2.479
x
|
2.713
x
|
4.868
x
|
4.163
x
|
3.181
x
|
2.819
x
|
Free Cash Flow
1 |
214
|
160
|
468
|
170
|
-77
|
177
|
330
|
407
|
ROE (net income / shareholders' equity)
|
9.22%
|
6.62%
|
15.5%
|
14.3%
|
-1.12%
|
4.94%
|
10.1%
|
10.3%
|
ROA (Net income/ Total Assets)
|
1.33%
|
1.37%
|
4.56%
|
5.06%
|
-0.39%
|
1.42%
|
3.15%
|
3.19%
|
Assets
1 |
-8,183
|
70,797
|
6,277
|
9,823
|
81,886
|
6,022
|
6,978
|
8,165
|
Book Value Per Share
2 |
5.270
|
11.80
|
13.00
|
15.30
|
12.30
|
12.60
|
13.40
|
13.90
|
Cash Flow per Share
2 |
2.950
|
2.450
|
4.690
|
3.810
|
1.180
|
3.100
|
3.270
|
-
|
Capex
1 |
198
|
195
|
272
|
428
|
261
|
393
|
323
|
308
|
Capex / Sales
|
7.49%
|
7.07%
|
7.61%
|
12.39%
|
9.16%
|
12.76%
|
9.7%
|
8.89%
|
Announcement Date
|
2/25/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
17.48
USD Average target price
17.88
USD Spread / Average Target +2.26% Consensus |
1st Jan change
|
Capi.
|
---|
| +23.45% | 2.76B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|